Trademark: 98287135
Word
ENDOSYME OBI
Status Date
Friday, December 1, 2023
Filing Date
Monday, November 27, 2023
5 Immunostimulants; Vaccines; Adjuvants for medical purposes; Anti-cancer preparations; Biological preparations for the treatment of cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer to be prevented or treated; Chemical reagents for medical or veterinary purposes; Enzyme preparations for medical purposes; Enzymes for medical purposes; Ferments for pharmaceutical purposes; Hormones for medical purposes; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the treatment and prevention of cancer to be treated; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Preparations of microorganisms for medical purposes; Tumor suppressing agents
The mark consists of stylized wording "EndoSyme OBI", and there is a curve line below "OBI".
The color(s) black and teal is/are claimed as a feature of the mark.
Mar 26, 2024
Teas Change Of Correspondence Received
Mar 26, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 26, 2024
Teas Change Of Owner Address Received
Jan 19, 2024
Notice Of Design Search Code E-Mailed
Jan 18, 2024
New Application Office Supplied Data Entered
Dec 1, 2023
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
